Bio-Modeling Systems SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted deductive integration (CADI), which is used in the discovery of new medicines and cosmetics. Its CADI platform undertakes contract research and internal research production in the areas of infection-immunology, inflammation, industrial biotechnology, cancer, tissue differentiation, dermatology and matabolism among others. The company caters to several pharmaceutical, cosmetic, biotechnologies, medical devices and diagnostic companies, among others. It provides novel hypotheses discovery and novel therapeutics diagnostics solution. BM Systems is headquartered in Paris, France.

Bio-Modeling Systems SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Licensing Agreements 12
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS - Key Competitors 13
Bio-Modeling Systems SAS - Key Employees 14
Bio-Modeling Systems SAS - Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Key Facts 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS, Key Competitors 13
Bio-Modeling Systems SAS, Key Employees 14

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Bio-Modeling Systems SAS - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted

USD 250 View Report

Bio-Modeling Systems SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted

USD 250 View Report

Bio-Modeling Systems SAS - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available